Beranda › Asma › Pennsylvania › Philadelphia
Uji klinis Asma di Philadelphia, PA
5 studi untuk Asma mencari peserta di lokasi sekitar Philadelphia (dalam radius sekitar 30 mil). Buka studi untuk melihat kriteria peserta dan cara menghubungi tim studi.
Teks studi resmi (Bahasa Inggris)
Merekrut peserta untuk studi di sini? Tampilkan di bagian atas halaman ini — $99 selama 30 hari →
Dose Range Finding Study to Assess Efficacy and Safety of Tozorakimab in Adults With Uncontrolled Asthma on Medium-to-High Dose Inhaled Corticosteroids
Menerima pesertaFase 2
- Research Site, Philadelphia
QUARTZ: Comparative Effectiveness of Switching From Albuterol to Albuterol/Budesonide Versus Adding Low-dose ICS or LTRA to Albuterol
Menerima pesertaStudi observasional
- Research Site, Wilmington · 25 mi jauhnya
A Randomized, Double-Blind, Placebo-Controlled Trial on Efficacy and Safety of Fluticasone Propionate/Albuterol Sulfate Combination in Participants 12 Years and Older With Asthma
Menerima pesertaFase 3
- Teva Investigational Site 12072, Philadelphia
Evaluating the Efficacy and Safety of PT027 Compared With PT007 Administered As Needed in Participants 12 to < 18 Years of Age With Asthma
Menerima pesertaFase 3
- Research Site, Wilmington · 25 mi jauhnya
Depemokimab Asthma Imaging and Bronchoscopy Sub-Study
Menerima pesertaFase 3
- GSK Investigational Site, Philadelphia
Uji klinis Asma di kota lain
- Miami, FL12 studi
- New York City, NY11 studi
- Boston, MA11 studi
- Oklahoma City, OK10 studi
- Durham, NC10 studi
- Dallas, TX10 studi
- Washington, DC9 studi
- The Bronx, NY9 studi
- Kansas City, KS8 studi
- Houston, TX8 studi
- St. Louis, MO7 studi
- Pittsburgh, PA7 studi
Studi lain di Philadelphia
- Kanker (semua jenis)59 studi
- Kanker Payudara56 studi
- Kanker Paru Non-Sel Kecil51 studi
- Kanker Metastatik46 studi
- Kanker Kolorektal44 studi
- Kanker Ovarium44 studi
- Kanker Prostat44 studi
- Kanker Paru36 studi
- Leukemia Mieloid Akut34 studi
- Gagal Jantung31 studi
- Kanker Endometrium28 studi
- Depresi26 studi
Dari ClinicalTrials.gov, data diambil 5 Okt 2026. Setiap studi menetapkan kriteria kelayakannya sendiri; tim studi yang menentukan siapa yang bisa bergabung.